Serratia marcescens Peritonitis in a Diabetic Patient Receiving Continuous Ambulatory Peritoneal Dialysis.
- Author:
Ji Hyoun KANG
1
;
Min Jee KIM
;
Yong Un KANG
;
Chang Seong KIM
;
Joon Seok CHOI
;
Eun Hui BAE
;
Seong Kwon MA
;
Soo Wan KIM
Author Information
- Publication Type:Case Report
- Keywords: Serratia marcescens; Continuous ambulatory peritoneal dialysis; Peritonitis
- MeSH: Abdominal Pain; Catheters; Cefazolin; Ceftazidime; Ciprofloxacin; Diabetes Mellitus, Type 1; Gentamicins; Humans; Leukocytes; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Serratia; Serratia marcescens
- From:Infection and Chemotherapy 2013;45(1):105-107
- CountryRepublic of Korea
- Language:English
- Abstract: We report a case of Serratia marcescens peritonitis in a 45-year-old man with insulin-dependent diabetes mellitus undergoing continuous ambulatory peritoneal dialysis (CAPD). The patient presented with abdominal pain and cloudy dialysate. Empiric antibiotic therapy was initiated intraperitoneally with cefazolin and ceftazidime for 5 days. Cultures of the dialysate revealed S. marcescens, and the treatment was subsequently changed to gentamicin and ceftazidime. Oral ciprofloxacin was also added. The patient's abdominal pain and the dialysate white blood cell (WBC) count, however, did not improve. The indwelling CAPD catheter was therefore removed. This is an unusual case report in the Korean literature of S. marcescens peritonitis in a patient receiving CAPD.
